Lipogems

Lipogems International Spa is an Italian multinational biotechnology company based in Milan, specializing in regenerative medicine through its proprietary Lipogems® system. The company is recognized as a leader in processing adipose (fat) tissue to support the natural repair of damaged tissues caused by various pathologies, particularly in orthopedics and musculoskeletal disorders. The Lipogems® system offers a minimally invasive alternative or adjunct to traditional surgical interventions, utilizing a patient’s own adipose tissue, which is rich in mesenchymal stem cells and growth factors with regenerative properties.

The procedure involves a small incision to harvest adipose tissue, which is then processed to create micro-fragmented fat that can be injected into affected areas. This approach is designed to reduce pain and inflammation, improve tissue function, and promote healing, with most patients experiencing short recovery times and a rapid return to daily activities. Lipogems’ products have undergone extensive clinical testing and are used worldwide, with over 140 scientific publications supporting their efficacy and safety, including follow-ups of up to five years. The company collaborates closely with physicians, surgeons, and researchers to advance innovative medical solutions and improve patient outcomes globally.

Keywords: regenerative medicine, adipose tissue, mesenchymal stem cells, Lipogems system, minimally invasive, orthopedics, tissue repair, biotechnology, Milan, pain reduction, inflammation, clinical trials, musculoskeletal disorders, medical innovation, patient recovery